Multiple sclerosis and pregnancy;Sclérose en plaques et grossesse

Revue Neurologique

Volumn 162, Issue 3, 2006, Pages 299-309

  Vukusic, S ^a   Confavreux, C ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Delivery; Hormones; Multiple sclerosis; Post partum; Pregnancy

Indexed keywords

ALFUZOSIN; AMITRIPTYLINE; AZATHIOPRINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BETA INTERFERON; CARBAMAZEPINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANTROLENE; ESTRADIOL; FLUOXETINE; FOLIC ACID; GABAPENTIN; GLATIRAMER; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYBUTYNIN; PREDNISOLONE; PREDNISONE; PROGESTERONE; SEX HORMONE; TROSPIUM CHLORIDE;

ABDOMINAL DISTENSION; BLEPHAROPHIMOSIS; BREAST FEEDING; CANCER RISK; CORRELATION ANALYSIS; CRANIOFACIAL SYNOSTOSIS; DISEASE ACTIVITY; DISEASE COURSE; EAR MALFORMATION; EMBRYOPATHY; EPIDURAL ANESTHESIA; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; HYPOTHESIS; INTRAUTERINE GROWTH RETARDATION; IRRITABILITY; LIMB MALFORMATION; LOGISTIC REGRESSION ANALYSIS; MECONIUM ILEUS; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; MUSCLE HYPOTONIA; NEURAL TUBE DEFECT; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY RATE; PROPHYLAXIS; PUERPERIUM; RECURRENCE RISK; RELAPSE; RESPIRATORY DISTRESS; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SLEEP DISORDER; STATISTICAL MODEL; TACHYCARDIA; THIRD TRIMESTER PREGNANCY; TREMOR;

EID: 33645788607     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75016-0     Document Type: Article

References (59)

1. ABRAMSKY O. (1994). Pregnancy and multiple sclerosis. Ann Neurol, 36: S39-S41.
2. ACHIRON A, ROTSTEIN Z, NOY S, MASHIACH S, DULITZKY M, ACHIRON R. (1996). Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis. J Neurol, 243: 25-28.
3. ACHIRON A, KISHNER I, DOLEV M et al. (2004). Effect of intravenous immunoglobulin treatment on pregnancy and post-partum related relapses in multiple sclerosis. J Neurol, 251: 1133-1137.
4. AMERICAN ACADEMY OF PEDIATRICS COMMITTEE ON DRUGS. (2001). Transfer of drugs and other chemicals into human milk. Pediatrics, 108: 776-789.
5. ARNASON BG, RICHMAN DP. (1969). Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis. Trans Am Neurol Assoc, 94: 54-58.
6. BADER AM, HUNT CO, DATTA S, NAULTY JS, OSTHEIMER GW. (1988). Anesthesia for obstetric patient with multiple sclerosis. J Clin Anesth, 1: 21-24.
7. BAMFORD C, SIBLEY W, LAGUNA J. (1978). Anesthesia in multiple sclerosis. Can J Neurol Sci, 5: 41-44.
8. BANSIL S, LEE HJ, HOLTZ CR, COOK SD. (1999). Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand, 99: 91-94.
9. BIRK K, RUDICK R. (1986). Pregnancy and multiple sclerosis. Arch Neurol, 43: 719-726.
10. CARTON H, VLIETINCK R, DEBRUYNE J et al. (1997). Risk of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry, 62: 329-333.
11. CONFAVREUX C, HUTCHINSON M, HOURS MM, CORTINOVIS-TOURNIAIRE P, MOREAU T. (1998). Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med, 339: 285-291.
12. CONFAVREUX C, HUTCHINSON M, HOURS M, CORTINOVIS-TOURNIAIRE P, GRIMAUD J, MOREAU T. (1999). Multiple sclerosis and pregnancy: clinical issues. Rev Neurol (Paris), 155: 186-191.
13. CONFAVREUX C. (2004). Intravenous immunoglobulins, pregnancy and multiple sclerosis. J Neurol, 251: 1138-1139.
14. CORREALE J, ARIAS M, GILMORE W. (1998). Steroid hormone regulation of cytokine scretion by proteolipid protein-specific CD4 + T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol, 161: 3365-3374.
15. DE SÈZE J, CHAPELOTTE M, DELALANDE S, FERRIBY D, STOJKOVIC T, VERMERSCH P. (2004). Intravenous corticosteroids in the post-partum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler, 10: 596-597.
16. DOUGLASS LH, JORGENSEN CL. (1948). Pregnancy and multiple sclerosis. Am J Obstet Gynecol, 55: 332-336.
17. DURELLI L, RICCI A, VERDUN E. (2003). Immunoglobulin treatment of multiple sclerosis: future prospects. Neurol Sci, 24: S34-S38.
18. DWOSH E, GUIMOND C, SADOVNICK AD. (2003). Reproductive counselling for MS : a rationale. Int MS J, 10: 52-59.
19. EBERS GC, SADOVNICK AD, RISCH N. (1995). A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaboratice Study Group. Nature, 377: 150-151.
20. EL-ETR M, VUKUSIC S, GIGNOUX L et al. (2005). Steroid hormones in multiple sclerosis. J Neurol Sci, 233: 49-54.
21. ELLIOT GA, GIBBONS AJ, GREIG ME. (1973). A comparison of the effects of Melengestrol Acetate with a combination of hydrocortisone acetate and medroxyprogesterone acetate and with other steroids in the treatment of experimental allergic encephalmyelitis in Wistar rats. Acta Neuropathol, 23: 95-104.
22. EVRON S, BRENNER T, ABRAMSKY O. (1984). Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits. Am J Reprod Immunol, 5: 109-113.
23. FERRERO S, PRETTA S, RAGNI N. (2004). Multiple sclerosis: mamagement issues during pregnancy. Eur J Obstet Gynecol Reprod Biol, 115: 3-9.
24. GILMORE W, WEINER LP, CORREALE J. (1997). Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol, 158: 446-451.
25. HAAS J. (2000). High dose IVIg in the post partum period for prevention of exacerbations in MS. Mult Scler, 6: S18-S20.
26. http://afssaps.sante.fr/htm/1/amm/amm0.htm. Répertoire des Spécialités Pharmaceutiques. Méthylprednisolone (hémisuccinate de). Solumédrol. Résumé des Caractéristiques du Produit. 21/11/2005.
27. HUTCHINSON M. (1993). Pregnancy in multiple sclerosis. J Neurol Neurosurg Psychiatry, 56: 1043-1045.
28. KEITH AB. (1978). Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats. J Neurol Sci, 38: 317-326.
29. KOENIG HL, SCHUMACHER M, FERZAZ B et al. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science, 268: 1500-1503.
30. KORN-LUBETZKI I, KAHANA E, COOPER G, ABRAMSKY O. (1984). Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol, 16: 229-231.
31. KURTZKE JF. (1961). On the evaluation of disability in multiple sclerosis. Neurology, 11: 686-694.
32. KURTZKE JF. (1983). Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology, 33: 1444-1152.
33. LEIBOWITZ U, ANTONOVSKY A, KATS R, ALTER M. (1967). Does pregnancy increase the risk of multiple sclerosis? J Neurol Neurosurg Psychiatry, 30: 354-357.
34. MCARTHUR JC, YOUNG F. (1986). Multiple sclerosis and pregnancy. In Goldstein RJ (ed.), Neurological disorders of pregnancy. 197-211. Futura Publishing Co., Inc., Mount Disco. New York.
35. MCFARLAND HR. (1969). The management of multiple sclerosis. 3. Apparent suppression of symptoms by an estrogen-progestin compound. Mol Med, 66: 209-211.
36. MUELLER BA, ZHANG J, CRITCHLOW CW. (2002). Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol, 186: 446-452.
37. ORVIETO R, ACHIRON R, ROTSTEIN Z, NOY S, BAR-HAVA I, ACHIRON A. (1999). Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol, 82: 191-194.
38. PETRI M. (2003). Immunosuppressive drug use in pregnancy. Autoimmunity 36: 51-56.
39. PICCINNI MP, GIUDIZI MG, BIAGIOTTI R et al. (1995). Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL4 production and membrane CD30 expression in established Th1 cell clones. J Immunol, 155: 128-133.
40. POSER S, RAUN NE, WIKSTROM J, POSER W. (1979). Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand, 59: 108-118.
41. POSER S, POSER W. (1983). Multiple sclerosis and gestation. Neurology, 33: 1422-1427.
42. POZZILI C, FALASCHI P, MAINERO C et al. (1999). MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology, 53: 622-624.
43. ROBERTSON NP, FRASER M, DEANS J, CLAYTON D, WALKER N, COMPSTON DAS. (1996). Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain, 119: 449-455.
44. ROULLET E, VERDIER-TAILLEFER MH, AMARENCO P et al. (1983). Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry, 56: 1062-1065.
45. SADOVNICK AD, EISEN K, HASHIMOTO SA et al. (1994). Pregnancy and multiple sclerosis: a prospective study. Arch Neurol, 51: 1120-1124.
46. SADOVNICK AD, DIRCKS A, EBERS GC. (1999). Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet, 56: 118-122.
47. SALEMI G, CALLARI G, GAMMINO M et al. (2004). The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand, 110: 23-26.
48. SICOTTE NL, LIVA SM, KLUTCH R et al. (2002). Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol, 52: 421-428.
49. SWEENEY WJ. (1953). Pregnancy and multiple sclerosis. Am J Obstet Gynecol, 66: 124-130.
50. SZEKERES-BARTHO J, WEGMANN TG. (1996). A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol, 31: 81-95.
51. TILLMAN AJB. (1950). The effect of pregnancy on multiple sclerosis and its management. Research publications - Association for Research in Nervous and Mental Disease, 28: 548-582.
52. TROOSTER WJ, TEELKEN AW, KAMPINGA J, LOOF JG, NIEUWENHUIS P, MINDERHOUD JM. (1993). Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha - etinylestradiol: an immunological study in the Lewis rat. Int Arch Allergy Immunol, 102: 133-140.
53. VAN WALDERVEEN MAA, TAS MW, BARKHOF F et al. (1994). Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology, 44: 327-329.
54. VOSKUHL RR. (2003). Hormone-based therapies in MS. Int MS J 10: 60-66.
55. VUKUSIC S, HUTCHINSON M, HOURS M et al., FOR THE PREGNANCY IN MULTIPLE SCLEROSIS GROUP. (2004). Pregnancy and multiple sclerosis (the Prims study): clinical predictors of post-partum relapse. Brain, 127: 1353-1360.
56. WHITAKER JN. (1998). Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med, 339: 339-340.
57. WORTHINGTON J, JONES R, CRAWFORD M, FORTI A. (1994). Pregnancy and multiple sclerosis: a 3-year prospective study. J Neurol, 241: 228-233.
58. ZORGDRAGER A, DE KEYSER J. (1997). Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci, 149: 95-97.
59. ZORGDRAGER A, DE KEYSER J. (1998). Premenstrual exacerbations of multiple sclerosis. J Neurol Neurosurg-Psychiatry, 65: 279-280.